��������

The Advisory Board Team at ExeVir comprises industry experts who provide strategic guidance and insights to streamline the development and commercialization of innovative antibody-based therapies. By leveraging their extensive experience in viral infectious diseases and biopharmaceuticals, the team helps shape the company's research direction and enhances stakeholder engagement, ensuring that ExeVir remains at the forefront of rapid viral control solutions.